NM_004360.5(CDH1):c.230T>C (p.Val77Ala) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Jul 3, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002442960.3
Allele description [Variation Report for NM_004360.5(CDH1):c.230T>C (p.Val77Ala)]
NM_004360.5(CDH1):c.230T>C (p.Val77Ala)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
RecName: Full=UDP-glucose 4-epimerase; AltName: Full=Galactowaldenase; AltName: ...
RecName: Full=UDP-glucose 4-epimerase; AltName: Full=Galactowaldenase; AltName: Full=UDP-galactose 4-epimerasegi|2494666|sp|Q56623.1|GALE_VIBCLProtein
-
Mus musculus telomeric repeat binding factor 2 (Terf2), transcript variant 4, no...
Mus musculus telomeric repeat binding factor 2 (Terf2), transcript variant 4, non-coding RNAgi|555290178|ref|NR_104410.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024